Beleave Inc.
BLEVF
Get informed when a big investor buys or sells
+ FollowMarket Cap$566
Close$
Share Statistics
| Market cap | $566.00 |
|---|---|
| Enterprise Value | $12.25 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.08 |
| Beta | -2.94 |
| Outstanding Shares | 526,680,877 |
Return
| Return on Equity | -221.94% |
|---|---|
| Return on Assets | -63.00% |
| Return on Invested Capital | -118.23% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 4.23 |
| Enterprise Value to EBIT | -1.01 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.01 |
| Debt to Equity | 1.73 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Beleave Inc.
16 employees
CEO: Vasilios Panagiotakopoulos Based in Oakville, Canada, Beleave Inc. operates primarily as a medical cannabis enterprise within the country. The firm's activities include both the cultivation and distribution of cannabis products, serving both the medical and recrea...